A group of 42 US states and territories has filed a fresh antitrust lawsuit accusing Swiss pharma Novartis (NOVN: VX) and its former generics unit Sandoz (SIX: SDZ) of colluding to fix prices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results